-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Exagen, Raises Price Target to $10

Benzinga·08/05/2026 19:36:44
Listen to the news
TD Cowen analyst Dan Brennan maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $8 to $10.